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Biomechanical, ultrastructural, 
and electrophysiological 
characterization of the non-human 
primate experimental glaucoma 
model
VijayKrishna Raghunathan  1,2,3, J. Seth Eaton1,2, Brian J. Christian4, Joshua T. Morgan1, 
James N. Ver Hoeve2,5, Chen-Yuan Charlie Yang6,7, Haiyan Gong6,7, Carol A. Rasmussen2,5,  
Paul E. Miller2,8, Paul Russell1,2, T. Michael Nork2,5 & Christopher J. Murphy1,2,9
Laser-induced experimental glaucoma (ExGl) in non-human primates (NHPs) is a common animal model 
for ocular drug development. While many features of human hypertensive glaucoma are replicated in 
this model, structural and functional changes in the unlasered portions of trabecular meshwork (TM) 
of laser-treated primate eyes are understudied. We studied NHPs with ExGl of several years duration. 
As expected, ExGl eyes exhibited selective reductions of the retinal nerve fiber layer that correlate 
with electrophysiologic measures documenting a link between morphologic and elctrophysiologic 
endpoints. Softening of unlasered TM in ExGl eyes compared to untreated controls was observed. The 
degree of TM softening was consistent, regardless of pre-mortem clinical findings including severity 
of IOP elevation, retinal nerve fiber layer thinning, or electrodiagnostic findings. Importantly, this 
softening is contrary to TM stiffening reported in glaucomatous human eyes. Furthermore, microscopic 
analysis of unlasered TM from eyes with ExGl demonstrated TM thinning with collapse of Schlemm’s 
canal; and proteomic analysis confirmed downregulation of metabolic and structural proteins. These 
data demonstrate unexpected and compensatory changes involving the TM in the NHP model of ExGl. 
The data suggest that compensatory mechanisms exist in normal animals and respond to elevated IOP 
through softening of the meshwork to increase outflow.
Glaucoma is a blinding disease of the retina and optic nerve, projected to affect over 70 million people worldwide 
by the year 20201. Retinal ganglion cells (RGC) are particularly sensitive to elevation in intraocular pressure 
(IOP), a common clinical feature of many forms of human glaucoma. In response, RGC bodies and their axons 
that comprise the retinal nerve fiber layer, (RNFL) undergo irreversible degeneration leading to loss of visual 
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function. Long-term glaucoma therapy often requires topical medications to reduce IOP, the majority of which 
act at the eye’s anterior segment to reduce aqueous humor production or enhance its outflow2–5.
The structure of the eye’s aqueous humor outflow system and its influence on IOP have been studied in 
humans and animals for many years and continue to be investigated. Of the available animal models, experi-
mental glaucoma (ExGl) in the non-human primate (NHP), induced by subtotal laser photocoagulation of the 
trabecular meshwork (TM), is considered the most predictive for drug efficacy in the human6. Morphological and 
hydrodynamic data in this model suggest that fibrosis of the TM and adjacent inner wall of Schlemm’s canal (SC) 
reduces the area for conventional aqueous outflow, leading to decreased outflow facility, and elevated IOP7–11. 
Furthermore, the classic arcuate mid-peripheral visual field losses observed in human patients with primary open 
angle glaucoma (POAG) and elevated IOP have also been observed in visual field testing of NHPs with ExGl12. 
Additional evidence suggests that aqueous humor flow in eyes with ExGl is largely diverted to the small unlasered 
area of TM, suggesting a capacity for this tissue to dynamically compensate both structurally and functionally, 
accommodating the increased flow9. Compensation has not, however, been directly demonstrated in this model.
It remains unclear whether tissue changes in the TM of human eyes with glaucoma represent primary struc-
tural abnormalities that lead to elevation of IOP, or develop as a consequence of chronically elevated IOP. Using 
atomic force microscopy (AFM), our group has previously shown that the matrix around the TM’s juxtacanali-
cular (JCT) region (adjacent to the inner walls of SC), is, on average, 20 times stiffer in tissue from glaucoma-
tous human eyes compared to that of non-glaucomatous donor eyes13. However, due to a history of chronically 
elevated IOP in the available glaucomatous donors, we were unable to identify whether TM stiffening was the 
primary event or a consequence of elevated IOP. If TM stiffening was a consequence of the latter, it would be 
anticipated that chronic elevation in IOP in the experimental primate model would result in similarly increased 
stiffness of the matrix.
To investigate this hypothesis, we obtained whole globes or corneoscleral buttons containing TM from cyno-
molgus monkeys (Macaca fascicularis) with chronic unilateral laser trabeculoplasty-induced ExGl. All animals 
had been previously used to screen topical hypotensive agents for efficacy in the context of glaucoma drug devel-
opment programs. Animals were euthanized for reasons unrelated to the study herein. Establishment and pro-
gression of ExGl had been thoroughly documented in these animals using a variety of electrodiagnostic and 
advanced ocular imaging approaches. In the context of these data, and to better understand and define structural 
changes of the anterior segment in this model, we analyzed the normal (non-lasered) regions of TM using AFM, 
proteomics, and confocal, light, and transmission electron microscopy (TEM).
Results
Compared to normal left eyes, all right eyes with ExGl maintained higher IOPs following laser trabeculoplasty for 
a minimum of 40.1 months (median 69.5 months; range 40.1–137.7 months) (Table 1). IOP values presented for 
right eyes with ExGl represent the mean ± SD for measurements taken for approximately 1 year prior to euthana-
sia. IOP values presented for untreated left eyes are those taken immediately prior of euthanasia.
Animal ID
IOP (mmHg) Prior to 
Euthanasia
Retinal Nerve Fiber Layer Thickness (µm) 
Measured Using In Vivo SD-OCT
ERG/VEP
Atomic Force 
Microscopy (AFM)
Proteomic 
Analysis
Transmission Electron 
Microscopy (TEM)
Mean ± SD OD 
(Right Eye) ††
OS  
(Left Eye) §
OD  
(Right Eye)
OS  
(Left Eye)
% Difference 
between OD and OS
Set A* 
(N = 3)
21 35.8 ± 4.4 18.0 57 109 47.71 ✓
34 36.6 ± 2.4 19.3 47 105 55.24 ✓
32 24.1 ± 2.8 22.0 100 112 10.71 ✓
Set B** 
(N = 6)
1 23.0 ± 1.4 18.0 29 106 72.64 ✓ ✓
2 43.4 ± 8.7 14.7 47 104 54.81 ✓ ✓
3 45.5 ± 9.9 21.2 43 94 54.26 ✓ ✓
4 48.5 ± 7.9 25.8 29 91 68.13 ✓ ✓
5 46.9 ± 11.5 22.7 32 106 69.81 ✓ ✓
6 56.4 ± 9.4 25.2 33 101 67.33 ✓ ✓
Set C† 
(N = 7)
28 26.8 ± 1.7 14.3 99 104 4.81 ✓ ✓
36 24.8 ± 1.5 20.7 104 109 4.59 ✓ ✓
19 29.5 ± 1.4 29.0 95 100 5.00 ✓
24 37.4 ± 4.1 23.0 41 92 55.43 ✓
10 30.8 ± 2.9 16.3 86 96 10.42 ✓
18 24.3 ± 1.6 15.3 85 89 4.49 ✓
20 24.0 ± 1.4 22.7 94 98 4.08 ✓
Table 1. Summary of intraocular pressure (IOP) measurements, retinal nerve fiber layer thicknesses, and other 
procedures and analyses performed prior to and following euthanasia. *Whole globes submitted for confocal, 
light, and transmission electron microscopy. **Corneoscleral rims submitted for proteomic analysis and/or 
atomic force microscopy. †Corneoscleral rims submitted for proteomic analysis only. ††Mean IOP ± SD OD 
from measurements taken over approximately 1 year prior to euthanasia. §IOP measurement OS immediately 
prior to euthanasia.
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SD-OCT and Retinal Nerve Fiber Layer Thickness (RNFLT). In eyes with ExGl, SD-OCT images from 
Set A and C animals demonstrated cupping of the ONH, neuroretinal rim thinning, and posterior displacement 
of the lamina cribrosa (see Fig. 1). Most Set B animals showed mild to moderate cupping. In Set A animals, both 
Cirrus™ and Spectralis™ instruments confirmed significant loss of RNFLT, and to comparable degrees, at each 
interval. Likewise, RNFLT measurements from each instrument, determined using both automated and manual 
segmentation algorithms, detected comparable loss of RNFL. As expected, most eyes with ExGl had reduced 
RNFLT compared to normal control eyes. Remarkably, however, considerable RNFLT thinning was not found in 
all eyes with ExGl (see Table 1).
Electrodiagnostics. ERG and VEP in ExGl. Certain features of the ERGs and VEPs elicited by both 
full-field flash stimulation and transient pattern reversal stimulation differed between ExGl and fellow control 
eyes. Figure 2 shows representative traces from dark adapted and light adapted flash intensity series, OPs, FVEP 
to full-field flash stimulation, and PERGs and PRVEPs to 2 Hz checkerboard stimulation. Full-field scotopic and 
photopic ERGs and A- and B-wave ERGs were similar between ExGl and control eyes at low and moderate flash 
strengths. However, ExGl amplitudes became relatively depressed in eyes with ExGl at high flash strengths (Fig. 3, 
asterisks). The data were fit to the hyperbolic non-linear function,
σ
=
•
+
V V I
I
max
n
n n
where Vmax is the maximal response, I = flash intensity, n = sensitivity exponent, and σ, the half-saturation con-
stant. The fitted curves show that Vmax is consistently lower in ExGl eyes whereas the threshold and gain are sim-
ilar between the eyes (see figure caption for details).
Figure 1. Representative pre-euthanasia OCT images from Animal Number 5 demonstrate optic nerve head 
(ONH) cupping, neuroretinal rim thinning, and posterior displacement of the lamina cribrosa. (OD = Right 
Eye; OS = Left Eye).
Figure 2. Examples of electrophysiologic recordings from Set B (n = 6 animals). ExGl eye indicated in red, 
fellow control eye in blue. (A) Dark-adapted full-field ERG flash intensity series. (B) Light adapted full-field 
single flash intensity series. Note the emergence of the photopic negative response (PhNR) at the higher flash 
strengths. (C) Oscillatory potentials (OPs) band-pass filtered from the DA 2.5 flash intensity ERG. (D) Light 
adapted full-field 30 Hz flicker. (E) Light adapted flash-evoked cortical potential (FVEP). (F) ERG evoked by 
checkerboard pattern reversing at 2 Hz (PERG). (G) cortical VEP evoked by the 2 Hz pattern stimulus.
www.nature.com/scientificreports/
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SD-OCT parameters including RNFLT, the Cirrus™ macular ganglion cell analysis (GCA, average) and mac-
ular thickness were examined for their relationship with electrophysiological functional measures. In Fig. 4, a star 
above the brackets in each graph indicates a significant difference (p < 0.05) in electrophysiology for the indicated 
parameter in full-field testing between eyes with ExGl and untreated control eyes. The location of the mean for 
the ExGl and control electrophysiology measures is indicated by downward ticks of the brackets. In all graphs, 
RNFLT and GCA differed significantly between ExGl and fellow control eyes; however, macular thickness did 
not differ. Figure 4 also shows that eyes with ExGl had consistently lower OPs, PhNRs, and FVEPs compared to 
control eyes. These features of the full-field ERG are thought to reflect function of second and higher-order reti-
nal neurons and are affected in human and experimental glaucoma14–16. Figure 5 shows a similar plot for pattern 
stimulation. As indicated by the starred brackets, PERG N95 and PRVEP P100 were significantly depressed in 
ExGl eyes. As expected, the PERG P50 wave, considered to reflect the macular retina relatively independent of 
retinal ganglion cells, was not affected by ExGl17,18. In contrast, the PERG N95 wave, which has been linked with 
retinal ganglion cell and optic nerve function in many studies, was significantly reduced in ExGl eyes compared 
with the fellow eye (Fig. 5). The PRVEP ‘P100’-like wave was also depressed in ExGl eyes, as would be expected 
based on anatomy and many studies in humans with glaucoma19,20.
Correlation Between Electrodiagnostic Measurements and RNFLT. Figures 4 and 5 show the relationship between 
SD-OCT measures and ExGl and fellow control eyes. A significant nonparametric correlation is indicated by a 
least-squares line. Note that there are 4 possible outcomes for each plot: ExGl and control eyes could differ 1) only 
in an OCT parameter and not differ in electrophysiology, 2) only in electrophysiology and not in OCT, 3) in both 
OCT and electrophysiology with no correlation between the two, and 4) outcome 3 plus a correlation between 
the anatomical measure and the functional measure. Figure 4 shows that certain electrophysiology measures from 
full-field ERG fall into outcome 4, namely OPs, PhNR and FVEPs, differ in ExGl and control eyes, which also 
differ in RNFLT and GCA but not macular thickness, and that these electrophysiology measures are positively 
correlated with RNFLT and GCA, but not with macular thickness. Similarly, Fig. 5, shows that the PERG N95 and 
PRVEP P100 wave were significantly lower in ExGl and that these measures correlate significantly with RNFLT 
Figure 3. Flash intensity series under dark- and light- adapted conditions for ExGl eyes (Red, triangles) and 
fellow control eyes (Blue, circles) in Set B (n = 6 animals). (A) Dark adapted a-wave amplitude versus flash 
strength. (B) Dark adapted b-wave amplitude versus flash strength. (C) Light adapted a-wave amplitude versus 
flash strength, (D) Light adapted b-wave amplitude versus flash strength. Data points fitted with compressive 
non-linear function (see text).
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and GCA, but not with macular thickness. Note that the PERG P50 wave is not correlated with RNFLT or GCA, 
as would be expected given the association with macular retinal response independent of ganglion cell function. 
Figure 4. Scatter plots illustrating mean differences and correlations between full-field electrophysiological 
measures and OCT measures of retinal nerve fiber layer thickness (RNFLT from manual segmentation of 
Spectralis™), average ganglion cell analysis from the Cirrus™ (GCA AV), and macular thickness estimates from 
the Cirrus™ (Mac Thickness) in Set B (n = −6 animals). Full-field electrophysiology parameters plotted versus 
OCT measures for ExGl (red, circles) and control (blue, triangles) eyes. Bracket tick marks indicate the means 
of the parameters for ExGl and control eyes. Significant differences between eyes for the parameter are indicated 
by asterisks. Significantly thinner segmented OCT layers were present in ExGl eyes, compared with controls, for 
RNFLT (p < 0.01) and GCA AV (p < 0.01), but not macular thickness (p > 0.6). Significantly lower amplitude 
electrophysiologic responses were present in ExGl eyes for full-field electrophysiology measures OPs (p < 0.01), 
PhNRs (p < 0.01), and FVEPs (p < 0.01). Significant correlations between RNFLT electrophysiology parameters 
are indicated by the presence of a gray line showing the least-squares linear fit. Significant correlations between 
RNFLT and the full-field electrophysiology measures were found for PhNR (p < 0.01), OPs (p < 0.01) and FVEP 
(p < 0.01), A–C). GCA AV also showed strong positive correlations with OP, PhNR and FVEP amplitudes, 
D–E) Macular Thickness was not affected by ExGl and was not correlated with these full-field electrophysiology 
measures G–I). Additional plots of full-field ERGs and OCTs are shown in the Supplemental Data.
www.nature.com/scientificreports/
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Fig. S1 shows that the full-field A- and B-waves recorded under light- and dark-adapted conditions, while differ-
ing between ExGl and Control eyes, show little relationship to the SD-OCT measures.
In summary, the results of a battery of non-invasive visual electrophysiologic measures presents a pattern 
that is consistent with the literature on these measures in human and experimental glaucoma. Full-field ERG 
responses were similar between ExGl and fellow eyes at low and moderate flash strengths; certain features of 
the full-field ERG, including the OPs and PhNR, which are ERG measures thought to depend on inner retinal 
function, were depressed in ExGl; pattern stimulation resulted in large differences between ExGl and fellow eyes. 
These functional measures are also correlated with RNFLT and the GCA. Of note, these measures were obtained 
using the Heidelberg Spectralis ™_ and Zeiss Cirrus™ instruments, the former measuring optic nerve head RNFL 
and the latter measuring ganglion cell and RNFL thickness around the macula (the agreement between the two 
machines measures of RNFLT was high; only the Spectralis™ RNFLT data are presented). There is very good 
Figure 5. Relationship between electrophysiology elicited by pattern-stimulation and OCT measure in 
eyes with ExGl (red, circles) and fellow control eyes (blue, triangles) from Set B (n = 6 animals). Significant 
differences between means and significant correlations indicated as in Fig. 4. PERG N95 and PRVEP P100, 
but not PERG P50 amplitudes were significantly lower in ExGl compared with fellow control eyes, indicated 
by starred horizontal brackets (]*). RNFLT was strongly correlated with PERG N95 and PRVEP P100, but not 
PERG P50, A–C). Likewise, PERG N95 and PRVEP P100 amplitudes were highly correlated with GCA AV, but 
not the PERG P50 (D–F). There was no correlation between Macular Thickness OCT and pattern-elicited ERG 
or VEP measures (G–I).
www.nature.com/scientificreports/
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agreement between the estimates of ganglion cell density and RNFLT, using different instruments, and their cor-
relation with functional measures. In contrast, the thickness of the central macula, relatively devoid of ganglion 
cells, was not correlated with the perturbation in electrophysiology measures resulting from ExGl.
Atomic Force Microscopy (AFM). We investigated if there were any correlation between elevated IOP and 
TM stiffness. The elastic moduli of the TM from both eyes of 6 animals (Set B) are shown in Fig. 6A. Elastic mod-
uli were also determined for 2 animals from Set C. The mean elastic moduli of the control TM was 3.31 ± 0.32 
kPa for Set B and 2.63 ± 0.14 kPa for two animals from Set C. Mean elastic moduli for the unlasered regions of 
TM in all eyes with ExGl were approximately 6-fold lower (0.464 ± 0.036 kPa for Set B, and 0.151 ± 0.014 kPa for 
Set C), indicating marked softening of the TM. Unexpectedly, the moduli values from the unlasered TM of eyes 
with ExGl were grouped around 300 Pa (i.e. 0.30 kPa), regardless of the difference in IOP between the eyes of the 
individual animals (Fig. S2). Even in the two Set C animals with only a small relative difference in the thickness of 
the RNFL, the elastic moduli of the TM were consistent with the values of the other monkeys measured.
Proteomic Analysis. A total of seven of the unlasered regions of TM samples obtained from eyes with ExGl 
(Set C) were directly utilized for proteomic analysis. Among these, TM samples from two monkeys with only 
small differences in the RNFL ratios (animals #28 and #36) were analyzed for proteomics after modulus measure-
ment. Principal component (PC) analysis was performed on the normalized spectral data of proteins comparing 
the ExGl group with control group. Scree plot demonstrated that 65% of the variance in the data was accounted by 
PCs 1 and 2 (Fig. S3). Clustering observed in the plot of PC1 versus PC2 demonstrated that significant differences 
in protein expression between groups existed (Fig. S3).
Approximately 1500 proteins were identified, and 11 proteins showed a significant difference (p < 0.05) in 
samples from normal and glaucomatous eyes, and are listed in Table 2. These 11 proteins include collagen VI 
(α3), as well as the matrix proteins osteoglycan, fibulin-1, NESH, and tenascin. Myocilin, a matricellular protein 
that is upregulated in TM after glucocorticoid treatment, was also found to be decreased. The exact functional 
role of myocilin in TM pathophysiology remains poorly understood but mutations in this gene have been shown 
to result in glaucoma21–24. A second group of proteins identified by the analyses was decreased in 5 of the samples 
and were close to or below the level of detection in the remaining samples. In this group of 23 proteins, several are 
associated with matrix (e.g. fibromodulin and complement factor H) while many are typically thought to be inter-
nal to cells. Since our samples were from fresh tissues, both TM cells and some inner walls of Schlemm’s canal 
(SC) would be present in our samples. Curiously, several enzymes were from the anabolic hexose monophosphate 
shunt, suggesting that this key metabolic pathway is down-regulated. Finally, a third group of 11 proteins was 
identified in 4 or 5 of the samples with the remaining samples below the level of detection. These proteins include 
collagen 1 (α2), collagen IV (α-1, 2, 4, and 5), heparin sulfate, proteoglycan, and laminin α5. All of these were 
significantly decreased in the samples from eyes with ExGl relative to the normal controls.
Morphological Changes. A total of 67 microscopic images (a minimum of 8 images per eye) were analyzed 
from 3 pairs of eyes of 3 animals (Set A) to evaluate ultrastructural changes to the TM, and the inner wall of SC 
and the JCT.
Trabecular meshwork thickness. TM thickness, measured in confocal images, was found to be significantly less in 
the high-tracer regions of eyes with ExGl (i.e. unlasered region of ExGl eyes) compared to similar regions of the 
normal eyes (mean 53.7 ± 3.1 vs. 127.4 ± 24.0 μm, p = 0.03) (Fig. 6B).
Fluorescence Intensity Measurement. While there was visually a trend towards greater amounts of tracers in the 
high-flow regions of the eyes with ExGl compared to normal eyes by examining the confocal microscopy images; 
this difference was not statistically significant as quantified by fluorescence intensity measurement (71.6 ± 6.3 in 
ExGL vs 57.4 ± 8.9 in normal eyes, p = 0.2 (Fig. 6C).
Height of SC. The height of SC was significantly narrower or collapsed in some regions in eyes with ExGl com-
pared to normal eyes. Mean SC height (the distance between the inner and outer walls of SC) was 12.3 ± 2.2 µm 
in ExGl compared to 25.0 ± 1.8 µm in normal eyes, p < 0.001 (Fig. 6D).
Giant vacuole density. To determine the giant vacuole (GV) density in light microscopic images, the length of 
inner wall of SC was analyzed ranged from 0.92–1.73 mm (the length being small due to only 1 clock-hour of 
tissue segment being left non-lasered in the eyes with ExGl). Significantly more giant vacuoles were found in the 
high-tracer regions of the normal eyes compared to those with high tracer regions with ExGl (mean 47 ± 9 vs 
11 ± 8 GVs per mm SC, p < 0.01) (Fig. 6E).
Ultrastructure of the inner wall of Schlemm’s canal (SC) and juxtacanalicular tissue (JCT). By TEM, similar mor-
phology was observed in the high-tracer regions of the JCT of both normal eyes and those with ExGl (i.e corre-
sponding to unlasered region of ExGl eyes), where the JCT was loose and expanded. More inner wall endothelial 
cells of SC appeared to be lost in the eyes with ExGl compared to the normal eyes (Fig. 6F).
Discussion
Most forms of glaucoma are associated with elevated IOP, believed to develop as a result of progressive reduction 
in aqueous outflow facility. In the animals in this study, sustained increase in IOP was successfully established 
by inducing subtotal fibrosis of the TM, effectively reducing outflow area. In these animals, in vivo OCT of the 
fundus confirmed the presence of characteristic features of ExGl including cupping of the ONH, neuroretinal 
rim thinning, posterior displacement of the lamina cribrosa, and decreased RNFL thickness, indicative of RGC 
www.nature.com/scientificreports/
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Figure 6. Comparison of results of atomic force microscopy (AFM), confocal microscopy, light microscopy, 
and transmission electron microscopy (TEM) between eyes with experimental glaucoma (ExGl/OD) and 
untreated control (OS) eyes (n = 8 animals for AFM; n = 3 animals for microscopy). (A) Box and whisker 
plots demonstrating the relative elastic moduli of untreated normal eyes (blue) and eyes with ExGl (red). (B) 
Comparison of the trabecular meshwork (TM) thickness between eyes with ExGl and normal control eyes. 
(i-ii): Representative confocal images show that the TM thickness (double arrow) was smaller in a high-tracer 
region of an eye with ExGl (i) compared to similar region of a normal eye (ii). SC = Schlemm’s canal. (iii): The 
TM thickness was significantly smaller in the high-tracer regions of eyes with ExGl compared to similar regions 
of the normal eyes. *: p < 0.05. Fluorescence of the tracer dye is indicated in red. (C) Fluorescence Intensity 
(i-ii) Representative confocal images showed no significant difference in (iii) fluorescence intensity between 
non-lasered regions of ExGl eyes and similar region of normal control eyes. (D) Height of Schlemm’s canal 
(SC). (i-ii): Representative light microcopy images showed that the (iii) height of SC was significantly narrower 
www.nature.com/scientificreports/
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loss25–28. As with humans, NHPs with advanced stages of glaucoma tend to exhibit a “floor effect” in SD-OCT 
derived measurements. With this phenomenon, RNFL and ganglion cell-inner plexiform layer (GCIPL) thick-
ness values level off, with RNFLT rarely falling below 35 µm, and almost never below 25 µm in NHPs, possibly 
due to the presence of residual glial or non-neural tissue (including blood vessels and displaced amacrine cells). 
Correspondingly, some electrodiagnostic abnormalities were expected in eyes with chronic ExGl and matched 
well with published data in humans with glaucoma18,29, while others were unexpected. Notably, there were strong 
correlations between OPs, PhNR, FVEP, PERG N95, P100 and RNFLT and GCA, but not with macular thickness. 
Other functional measures, including scotopic and photopic full-field ERG single-flash a- and b-waves did not 
demonstrate a corresponding correlation (see supplemental figures). Selective reduction of the ERG waveforms 
elicited only at high intensity levels argues against optic nerve injury alone being the sole retinal damage caused 
by glaucoma30–33. It is of interest that in ExGl eyes, there was a relatively reduced full-field ERG A- and B-wave 
amplitude at the highest flash intensities. It is unlikely that this is the consequence of ischemic processes following 
elevation of IOP, since the response to dim flashes was not affected and responses are not correlated with RNFLT 
thinning. Furthermore, it suggests that optic nerve injury alone cannot account for the results, since optic nerve 
transection does not lower ERG amplitudes15,34. One possibility that has been suggested by Nork et al., is that 
Group 1 - Decreased In 
All Samples
Group 2 - Decreased In 5/7 Samples (Undetected 
In Others)
Group 3 - Decreased In 4/7 Samples 
except #11; Not detected in #7 or #8)
Collagen α3 (VI)71 Fibromodulin72,73 Collagen α2 (I)
Prelamin A/C Gelsolin74 Collagen α1 (IV)
Histone H2B75 Serotransferrin76 Collagen α(4 (IV)
Alpha enolase77,78 Glyceraldehyde-3-phosphate dehydrogenase Basement membrane-specific heparin sulfate proteoglycan
Myocilin79 Fructose bisphosphate aldolase A Smooth muscle actin
Osteoglycan80 Transketolase Emulin
Fibulin-181 Phosphoglycerate kinase-1 Laminin α-5
Tenascin82 Immunoglobulin ƛ Fibulin-5
Nesh-SH383 Retinal dehydrogenase Collagen α5 (IV)
Immunoglobulin γ Collagen α2 (IV)
α-2-macroglobulin84 Aldehyde dehydrogenase
Immunoglobulin α
Elongation factor 1-α
Triosephosphate isomerase78
Sushi repeat protein SRPX285
Procollagen C-endopeptidase enhancer 186
Serpine peptidase inhibitor87
Dihydropyrimidinase related protein 3
Destrin
Cofilin-1
Apolipoprotein E88
Complement factor H89
Phosphoglycerate mutase78
Table 2. Proteins decreased at least 2-fold in the unlasered trabecular meshwork (TM) of monkey eyes with 
experimental glaucoma (ExGl).
in ExGl than normal control eyes (red lines). SC was collapse in the some regions (arrows) in ExGl eyes. (E): 
Giant vacuole density. (i-ii): Representative light microcopy images showed significantly fewer giant vacuoles 
in the non-lasered region of an eye with ExGl (i) compared to the high-tracer region of a normal eye (ii). (iii): 
Significantly more giant vacuoles were found in the high-tracer region of normal eyes compared to the non-
lasered region of eyes with ExGl (*p < 0.05). (F) Comparison of ultrastructure of the Schlemm’s canal (SC) and 
juxtacanalicular tissue (JCT) between eyes with ExGl and normal control eyes. (i): A representative electron 
microscopy image of the JCT and inner wall of SC from an eye with ExGl. Loose and expanded JCT was seen in 
the high-tracer region (arrow). SC was narrower compared to normal control eye, some inner wall endothelial 
cells along SC were lost (arrowheads), and some tracers were observed inside SC. More tracers were observed 
in the high-tracer regions of the eyes with ExGl compared to normal eyes. (ii): An electron microscopy image of 
the JCT and inner wall region from a normal eye. Loose and expanded JCT was seen in the high-tracer region 
(arrow). SC was open and inner wall cells were intact. (iii): Percent length of SC missing inner wall endothelial 
cells. More inner wall endothelial cells along SC appeared to be lost in the eyes with ExGl compared to the 
normal eyes.
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there may be a process in ExGl initiated by transient ischemia of cone photoreceptors that is relatively independ-
ent of a direct IOP-induced ganglion cell death pathway33. This could result in a reduced response to bright flashes 
that recruit cones in the dark-adapted eye as well as responses to strong flashes that also contain a contribution 
from cone photocurrent.
It is noteworthy that among the animals included in this study, there was a range of RNFL thinning, as pre-
viously reported with optic nerve axon counts in NHPs with ExGl33. In some eyes with ExGl, including two that 
eventually underwent AFM, RNFL thinning was minimal compared to control eyes, indicating mitigated damage 
to RGCs, despite documented elevation in IOP. These data are consistent with previous reports showing that some 
animals and human patients are more resistant to loss of RGCs even with high IOPs25,27,33, and may be analogous 
to human patients with clinically normal visual fields despite ocular hypertension35,36. Interestingly, AFM in the 
same two animals mentioned above demonstrated a decrease in stiffness in the JCT area in the unlasered region 
of the eye with ExGl similar to that of the first six animals that were measured. Thus, these data strongly suggest 
that any relative neuroprotection in these eyes is likely mediated by a mechanism independent of the compensa-
tory softening of the TM and JCT.
The consistent and marked softening of the unlasered portion of the TM in eyes with chronic ExGl represents 
a biomechanical alteration, to our knowledge, previously undocumented in NHPs with laser-induced ExGl. A 
principal limitation of our investigation is the lack of knowledge as to the mechanism of action or class of the 
topical agents previously administered to these NHPs, as well as the need for sporadic to frequent treatment to 
manage excessively high IOP in 4 eyes with ExGl in Set B. There are known structural effects of prostaglandin 
analogs (PGAs) and beta blockers on the TM37–41. In NHPs, sustained, long-term administration of PGAs and 
beta blockers have been shown to structurally alter the TM in vivo, with changes ranging from loss of TM and 
partial collapse of SC to complete rarefaction, respectively40,42. However, we believe any confounding effect of 
this treatment on our results would be mitigated by the short duration and intermittent nature of treatment in 3 
of the 4 animals. Furthermore, the decrease in the elastic modulus in these 4 eyes suggested that tissue softening 
occurred to the same degree as 4 eyes not receiving any additional treatment with the aforementioned drugs 
during the year prior to euthanasia.
While chronic administration of PGAs and beta blockers may structurally alter TM, the mechanism of action 
of these drug classes does not specifically target TM to reduce IOP. Classes like the rho kinase (ROCK) inhibitors, 
however, specifically target the TM to increase conventional aqueous outflow and lower IOP by inducing rapid, 
but reversible, structural relaxation of associated smooth muscle43–47. Therefore, similar effects on the TM follow-
ing administration of such agents to these animals must be considered when interpreting our results. Although 
we were masked to the class and mechanism of the test articles administered to these monkeys, we believe the 
study designs and nature of our findings also mitigate this possible confounding factor. Firstly, the vast majority 
of studies conducted using the animals presented here involved only brief, single-dose instillation of a test article, 
and none specified administration of any test article for greater than 3 days duration. The brevity of these studies 
were designed to minimize the possible effect of daily IOP fluctuation which can be a prominent limitation of 
this model.48 In this study, we report prominent morphological and ultrastructural changes in the ExGl eyes (i.e. 
decreased TM thickness, decreased giant vacuole formation). Such changes have not been reported in the past49, 
although more recently, Netarsudil, an inhibitor of Rho kinase/norepinephrine transporter, was reported to sig-
nificantly increase the size of giant vacuoles in the Schlemm’s canal of non-glaucomatous eyes perfused ex vivo 
without altering its density50. Whether Netarsudil or other drug class have different effects on TM morphology/
structure in glaucomatous vs non-glaucomatous models remains to be seen. In addition, even in the two animals 
with only a small difference in RNFL thickness between the ExGl eye and the control, the elastic moduli of the 
TM were consistent with the values of the other monkeys measured despite a marked difference in washout 
period prior to euthanasia in these two (2.7 months vs 26.9 months).
The data presented here suggest that a softer TM promotes increased outflow, provided by the capacity for 
unlasered primate TM cells in normal primate eyes to compensate for increased IOP and reduced overall outflow 
from the eye by altering the composition and subsequent mechanical properties of the matrix in the JCT region. 
It is also noteworthy that, regardless of RNFL thickness, the elastic modulus in all eyes with ExGl were similarly sof-
tened, suggesting that the unlasered TM had reached a lower limit for compositional or organizational remodeling. 
However, the time taken to achieve such softening could not be determined from the specimens available for 
investigation. To our knowledge, this is the first demonstration of tissue softening that highly suggests dynamic 
compensation of the normal NHP TM under supraphysiological load. Importantly, these data suggest that in 
the normal animal compensatory mechanisms exist that result in a softening of the meshwork in the face of 
chronically elevated IOP. The fact that glaucomatous humans exhibit a markedly increased stiffness (20-fold) 
suggests that individuals with POAG have a disruption of this compensatory mechanism. We acknowledge that 
the exact molecular mechanism(s) responsible for this compensation in the normal primate eye at this time 
remain unidentified. We also acknowledge that these tissue changes were observed in samples representing only 
a small portion (<10%) of the total TM, and that samples providing a temporal context of these TM changes, 
both immediately following laser treatment(s) and with respect to establishment of ocular hypertension would 
provide valuable insight. These data are beyond the scope of the current study, but we believe that the presence of 
a compensatory remodeling mechanism to explain our biomechanical results is well-supported by accompanying 
proteomic, morphological, and ultrastructural data.
Proteomic analysis of TM provides further insight into possible mechanisms of the tissue softening observed 
at the JCT in these samples. In eyes with ExGl, multiple matrix components were down-regulated including 
collagens and other structural matrix proteins. Recent studies using knockout mouse models lacking expression 
of MMP-9 have demonstrated spontaneous increased aqueous outflow resistance and ocular hypertension, in 
association with deposition of aberrant collagen in the TM51,52. Multiple enzymes related to cellular metabolism 
were also down-regulated and this may be a result of reduced cell numbers in the TM, as previously observed in 
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glaucomatous patients53–55. Rapid alterations in TM mechanics are feasible as recently demonstrated by our group 
using a steroid-treated rabbit model56. Once softened to baseline level, only some remodeling of the ECM might 
be necessary and could signal TM cells to modify their metabolism since renewal of the ECM might be severely 
curtailed subsequently. These data would be strengthened by comparison to proteomic data from lasered TM 
tissue in ExGl eyes. These data, however, are not available at this time, and limit interpretation of our proteomic 
findings.
The morphological analysis presented here clearly demonstrates thinning of the unlasered regions of the TM 
in eyes with ExGl, with the SC collapsed and with substantially decreased giant vacuole formation. Concurrently, 
proteomic analysis demonstrated a clear downregulation of metabolic, structural, and matricellular proteins 
accompanied by a reduction in the elastic modulus emphasizing a dysfunctional meshwork. The findings from 
this analysis also suggest that compensatory softening and increased aqueous flow may correspond to ultras-
tructural abnormalities such as disruption of cellular processes, local cellular tight junctions and/or adhesion to 
the extracellular matrix, and loss of giant vacuole formation. Previous studies have reported increased ability for 
the expansion of giant vacuoles with increased IOP in normal eyes7,57–60, and an inhibited ability for both pore 
and giant vacuole formation in POAG61–63. Data from this study show decreased vacuole formation of inner wall 
endothelial cells of SC in normal cynomolgus eyes with long term elevation of IOP as a result of major alterations 
in the JCT. When taken in context with our findings, these reports suggest that up-regulation of vacuole forma-
tion is lost with time in the face of elevated IOP, and may not reflect a primary molecular dysregulation in matrix 
dynamics.
Furthermore, studies have shown that aqueous humor outflow from the eye is segmental, being high in some 
regions of the TM, and low in others64,65. Therefore, novel therapeutic agents that specifically target the TM should 
ideally aim to upregulate aqueous egress in lower-flow areas. Interestingly, the TM moduli for all 8 monkeys with 
ExGl in this study were approximately the same, regardless of the difference in IOP values between eyes with 
ExGl and controls, suggesting that the observed changes may represent an outer limit of compensatory softening. 
The discovery that compensatory matrix softening is intrinsic to this ExGl model suggests strong limitations as 
to its predictive value in drug discovery and development programs. Thus, potentially viable therapeutic agents 
could be withdrawn because of apparent lack of efficacy (i.e. false negative). If a drug’s mechanism of action is to 
enhance aqueous outflow and reduce IOP by altering the extracellular matrix, this model does not represent an 
ideal test system.
In conclusion, these data provide important insights into anterior and posterior segment changes in the NHP 
model of laser-induced ExGl. Despite chronic elevation in IOP, considerable RNFL thinning may not be observed 
in some monkeys, and may not correlate with all electrodiagnostic parameters. These results suggest that such 
discrepancies may be due to underlying genetic/epi-genetic mechanisms that are yet to be identified in future 
studies. This is particularly important considering that not all human POAG patients observe direct correlation 
between IOP and RNFL thinning. Despite structural and functional variation at the level of the retina in vivo, 
ex vivo analyses demonstrate more consistent findings. Ultrastructurally, the unlasered TM is thinned and rel-
atively acellular with reduced giant vacuole counts along the inner wall of SC. The TM at the JCT is invariably 
and maximally softened in eyes with ExGl. Correspondingly, proteomic analysis demonstrates consistent down-
regulation of numerous structural proteins and metabolic enzymes. Collectively, these findings suggest dynamic 
compensation within the TM in normal animals in response to elevated IOP, a critical response that may be 
lacking in human patients with POAG, and underscore the need for further investigation of structural changes to 
the aqueous outflow pathway in this model. Importantly, despite in vivo findings that support use of this model 
in investigations of neuroprotection, the presence of compensatory alterations in the aqueous outflow pathway in 
unlasered regions limit the utility of this model in evaluation of therapies that target the TM.
Materials and Methods
Animals. Thirty-two eyes of 16 adult female cynomolgus macaques (Macaca fascicularis) were analyzed 
in the course of this study. All experimental methods and procedures were approved by the Animal Care and 
Use Committee at Covance Laboratories, Inc. (Madison, WI), and were performed consistent with the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research. At least 40 months prior to euthanasia 
and globe collection, all animals had undergone unilateral laser trabeculoplasty (right eye [OD] only) to induce 
ExGl. A total of 3 diode laser treatments were used to ablate the majority (approximately 11 clock-hours) of the 
TM of all right eyes to induce unilateral ExGl. Thereafter, all animals had been used in preclinical investigations 
evaluating the hypotensive efficacy of topical test substances. In those investigations, all personnel involved were 
masked to the identity of the test articles. The vast majority of these investigations involved instillation of a single 
topical dose of a test article and measurement of IOP for a 24 hour period, followed thereafter by at least 2 weeks 
of washout period without any treatment. No studies involved administration of any test article for greater than 
3 days duration. Prior to euthanasia, all animals had undergone washout periods (median 22.4 months; range 
2.0–37.0 months) without any topical test articles prior to euthanasia. During the year prior to euthanasia, four 
of the animals in Set B (Numbers 3–6) required variable treatment with a topical beta blocker or prostaglandin 
analog (PGA) to manage excessively elevated IOP ( ≥ 40 mmHg) and ensure animal welfare. In three of these ani-
mals this treatment was sporadic, last performed 51 days prior to euthanasia in two, and 15 days prior to eutha-
nasia in one. One animal (Number 6) required more frequent treatment, even until the day prior to euthanasia. 
Inclusion criteria (age, duration between onset of glaucoma and euthanasia, and washout period) for all animals, 
designated as Sets A-C, are presented in Table 3. All in vivo and ex vivo measurements and procedures performed 
for these animals are summarized in Table 1. Whole globes from Set A animals were submitted for confocal, light, 
and transmission electron microscopy (TEM); corneoscleral rims from Set B and C animals were submitted for 
proteomic analysis and/or atomic force microscopy (AFM). 
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Laser Trabeculoplasty Procedure and Establishment of Experimental Glaucoma (ExGl). All laser 
trabeculoplasty procedures were performed by a board-certified veterinary ophthalmologist with extensive expe-
rience in comparative glaucoma research. Details of surgical procedures are provided in supplementary materials.
In Vivo Optical Coherence Tomography and Electrodiagnostics. Spectral-domain optical coherence 
tomography (SD-OCT) scans of the fundus were carried out in both eyes of all animals using a Zeiss™ Cirrus 
HD-OCT 4000 (Cwarl Zeiss, Oberkochen, Germany) and/or Heidelberg™ Spectralis HRA + OCT (Heidelberg 
Engineering, Heidelberg, Germany) instrument prior to euthanasia. Evaluation of scans focused on the RNFL, 
retinal ganglion cell layer (RNGL), optic nerve head (ONH), and macula. Segmentation and determination of 
RNFL thickness (RNFLT) was performed using standard automated algorithms as well as manual and com-
bined (EdgeSelect™) techniques66. Scotopic and photopic full-field ERGs (ffERG) to a series of flash strengths, 
photopic flash visual-evoked potentials (fVEP), pattern electroretinograms (PERG) and pattern reversal visual 
evoked potentials (PRVEP), in that order. Measurements were recorded under anesthesia in two sessions using a 
BigShot™ electrodiagnostic system (LKC Technologies™, Gaithersburg, MD). Details on the experimental con-
ditions and animal subsets are provided in supplementary materials.
Collection and Fixation of Globes. Following euthanasia, all eyes were immediately enucleated and all 
right eyes with ExGl were marked to facilitate identification of the unlasered area of the TM. For AFM and pro-
teomics (Sets B and C), corneoscleral rims were dissected, placed in Optisol™ and refrigerated before shipping 
from Covance Laboratories to the University of California – Davis. For confocal and light microscopy and TEM 
(Set A), whole globes were similarly enucleated and refrigerated, each placed in a moist container, and shipped 
refrigerated to Boston University within 24 hours of euthanasia.
Atomic Force Microscopy (AFM). Within 24 h post-euthanasia, tissue samples were received at UC Davis 
for AFM. After receipt, the unlasered portion of TM from right eyes (OD) with ExGl (Sets B and C) was micro-
dissected according to data from the surgeon’s records, and the corresponding marking designated at enucleation. 
The elastic modulus determined using AFM according to methods previously described for human TM13,56,67. A 
similar dissection was done for the normal left eyes (OS) and AFM performed using a portion of TM of approxi-
mately the same size as the samples from eyes with ExGl. All force vs. indentation curves were obtained using the 
MFP-3D BIO system (Asylum Research™, Santa Barbara, CA). Force curves (5 per location) were obtained from 
5 random locations along the length of the tissue.
Proteomics. Within 24 h post-euthansia, tissue samples were received at UC Davis for proteomic analysis. 
Unlasered TM tissue was microdissected from ExGl eyes and controls using the technique described above. 
Isolated tissue samples were immediately digested in RIPA buffer, homogenized, and stored at −80 °C until 
analysis. Samples were precipitated and analyzed as described previously56,68. Mass spectra were collected in a 
data-dependent mode.
Confocal, Light Microscopy (LM) and Transmission Electron Microscopy (TEM) 
Morphology. Immediately following enucleation, both eyes from Set A animals were refrigerated and shipped 
to Boston University for ocular perfusion, confocal, light microscopy (LM), and TEM of TM from untreated eyes 
Animal ID Age (months)*
Duration Between Onset of ExGl 
and Euthanasia (months) Washout Period Prior to Euthanasia (months)
Set A** (N = 3)
21 116.9 75.4 2.3
34 113.5 58.8 26.4
32 109.5 58.8 2.0
Set B† (N = 6)
1 149.5 119.2 24.1
2 153.5 115.6 21.2
3 76.1 44.7 23.9
4 101.7 56.9 37.0
5 79.0 44.5 23.7
6 86.8 40.1 27.3
Set C†† (N = 7)
28 98.8 63.6 2.7
36 104.8 59.2 26.9
19 115.5 75.8 2.7
24 115.7 75.4 33.4
10 170.9 137.7 3.9
18 114.7 75.4 2.3
20 115.5 75.4 3.9
Table 3. Inclusion criteria for all animals with unilateral (right eye [OD] only) experimental glaucoma (ExGl). 
*At date of euthanasia. **Whole globes submitted for confocal, light, and transmission electron microscopy. 
†Corneoscleral rims submitted for proteomic analysis and/or atomic force microscopy. ††Corneoscleral rims 
submitted for proteomic analysis only.
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and the non-lasered regions of eyes with ExGl. The last measurement of IOPs on the day of sacrifice were used for 
the analysis and to set the subsequent perfusion pressure.
Ex vivo ocular perfusion. Enucleated eyes were perfused with Dulbecco’s phosphate-buffered saline containing 
5.5 mM D-glucose (GPBS) with the perfusion pressure set at the pre-mortem intraocular pressure minus 7 mmHg 
(episcleral venous pressure) for 15–30 minutes. This time was set based on previous reports for establishing a sta-
ble outflow facility8. A previously established two-color fluorescent tracer method69 was used to label the aqueous 
outflow patterns (green or red tracers; 500 or 200 nm; 0.002%). The anterior chamber contents were exchanged 
prior to perfusion with the same perfusates (tracers, GPBS, and fixative). All eyes were perfused with a fixed vol-
ume. Eyes were perfusion-fixed with modified Karnovsky’s fixative and immersed-fixed overnight with the same 
fixative before further processing.
Fluorescent tracer distribution in the TM and TM thickness by confocal microscopy. The eyes were hemisected 
along the equator, and the vitreous humor, ciliary body and lens were removed. Tracer distribution from the 
TM sides of the anterior chamber was imaged by a global imaging technique70 using a 300mm lens on a 4000MP 
VersaDoc™ imaging system (Bio-Rad Laboratories, Hercules, CA). The tracer distributions from the TM served 
as guides for later dissection of the hypertensive eyes correlating to non-lasered regions where tracers were 
observed, and lasered regions where tracers were not observed (Fig. S4). The anterior segments of the eyes were 
further divided into smaller wedges. For normal control eyes, tissue regions similar to the non-lasered regions of 
hypertensive eyes were used to analyze the TM thickness with confocal microscopy (Carl Zeiss 510, Axiover™ 
200 M Laser Scanning Microscope, Carl Zeiss) and the Schlemm’s canal/juxtacanalicular tissue (SC/JCT) regions 
with electron microscopy. Each confocal image was measured at two to three different locations for TM thickness 
(the length from the innermost uveoscleral beam to the inner wall endothelium of SC), and the average thickness 
of TM in high-tracer regions of the ExGl and normal control eyes were then calculated and analyzed. The average 
fluorescence intensity was measured using ImageJ (v1.46; National Institutes of Health, Bethesda, MD, USA) and 
compared between ExGl and normal control eyes. For each image, a ~10 µm wide rectangular strip was drawn 
along the inner wall of SC. Average intensity per pixel was measured in the area in 8-bit images; 0 was the mini-
mum and 255 was the maximum value of fluorescence intensity.
Giant vacuoles density and ultrastructure of the inner wall of Schlemm’s canal and juxtacanalicular tissue. After 
confocal imaging, semi-thin frontal tissue sections were fixed, cut, and stained with 1% Toluidine Blue (Fisher 
Scientific, Pittsburgh, PA). Light micrographs along the inner wall of the SC were taken using the Olympus™ 
FSX100 imaging system with a 40X objective. The height of SC (the distance between the inner and outer walls 
of SC) was measured and compared between normal control and ExGl eyes. A total of 6–12 measurements along 
SC were made to obtain the average SC height for each eye. The number of giant vacuoles was counted along the 
inner wall of SC where the SC was open. Ultra-thin sections were cut and the ultrastructure of the inner wall of 
SC and JCT regions were examined with a transmission electron microscope (JOEL™ JEM-1011, Tokyo, Japan). 
The percentage of SC length missing inner wall cells was then measured from the electron micrographs.
Statistical analysis. Differences in ERG parameters were evaluated by paired-sample t-tests. Correlation 
with SD-OCT RNFL thickness was assessed with non-parametric Spearman’s rho coefficient. For AFM meas-
urements, elastic modulus was represented as either box plots or bar charts (mean ± standard error in mean) 
from both eyes. Statistical significance was determined by performing unpaired Student’s t-test between the two 
groups for each animal (*p < 0.05, **p < 0.01, ***p < 0.001). To ascertain quantitative differences in biochem-
ical composition of the TM derived from the lasered and unlasered eyes, nano-scale liquid chromatography 
tandem-mass spectrometry was performed. Proteomics data were analyzed using the built-in features of Scaffold 
viewer (Proteome Software Inc., OR). Normalized total spectral counts from the TM samples were compared for 
fold-change between the OS and OD eyes. Fisher’s exact test was performed to account for relative abundance in 
proteins between the groups. For morphological analysis, unpaired two-tailed Student’s t-test was used for statis-
tical analysis; results are shown as mean ± standard deviation (SD).
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